According to REGENXBIO's latest financial reports the company's current revenue (TTM ) is ยฃ0.12 Billion. In 2024 the company made a revenue of ยฃ66.4 Million a decrease over the revenue in the year 2023 that were of ยฃ70.83 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.